The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway

Biochemical and Biophysical Research Communications

Volumn 396, Issue 2, 2010, Pages 555-561

  Liu, Yanling ^a   Xu, Sanpeng ^a   Xiao, Fei ^a   Xiong, Yan ^a   Wang, Xiaojin ^a   Gao, Sui ^a   Yan, Weiming ^a   Ning, Qin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alveolar macrophages; COPD; FGL2; MAPK

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CD11B ANTIGEN; CD14 ANTIGEN; CD71 ANTIGEN; FIBRINOGEN LIKE PROTEIN 2; FIBROLEUKIN PROTHROMBINASE; GELATINASE B; GLYCOPROTEIN P 15095; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKEMIA CELL LINE; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MACROPHAGE ACTIVATION; MIGRATION INHIBITION; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AGED; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FIBRINOGEN; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; THROMBOPLASTIN;

EID: 77952745051     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.145     Document Type: Article

References (20)

1. Chung K.F., and Adcock I.M. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur. Respir. J. 31 (2008) 1334-1356
2. Barnes P.J. Alveolar macrophages as orchestrators of COPD. COPD 1 (2004) 59-70
3. Sarir H., Henricks P.A., and van Houwelingen A.H. Cells, mediators and toll-like receptors in COPD. Eur. J. Pharmacol. 585 (2008) 346-353
4. Chan C.W., Chan M.W., and Liu M. Kinetic analysis of a unique direct prothrombinase, FGL2, and identification of a serine residue critical for the prothrombinase activity. J. Immunol. 168 (2002) 5170-5177
5. Chan C.W., Kay L.S., and Khadaroo R.G. Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J. Immunol. 170 (2003) 4036-4044
6. Foerster K., He W., and Manuel J. LPS-induced occult loss in mice requires FGL2. Am. J. Reprod. Immunol. 58 (2007) 524-529
7. Liu M., Mendicino M., and Ning Q. Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J. Immunol. 176 (2006) 7028-7038
8. Ning Q., Sun Y., and Han M. Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection. J. Immunol. 174 (2005) 7403-7411
9. Zhu C.L., Yan W.M., and Zhu F. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J. Gastroenterol. 11 (2005) 6936-6940
10. Yan W.M., Huang J.Q., and Luo X.P. FGL2 prothrombinase/fibroleukin gene expression in lung impairment in a murine severe acute respiratory syndrome model. Virol. Sin. 22 (2007) 181-192
11. Su K., Chen F., and Yan W.M. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma. World J. Gastroenterol. V14 (2008) 5980-5989
12. Schubert R., Geiger H., and Zielen S. Simultaneous detection of ERK-, p38-, and JNK-MAPK phosphorylation in human adipose-derived stem cells using the cytometric bead array technology. J. Immunol. Methods 350 (2009) 200-204
13. Brass D.M., Hollingsworth J.W., and McElvania-Tekippe E. CD14 is an essential mediator of LPS-induced airway disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 293 (2007) L77-L83
14. Georgakopoulos T. Integrin CD11c contributes to monocyte adhesion with CD11b in a differential manner and requires Src family kinase activity. Mol. Immunol. 45 (2008) 3671-3681
15. Renda T., Baraldo S., and Pelaia G. Increased activation of p38 MAPK in COPD. Eur. Respir. J. 31 (2008) 62-69
16. Tudhope S.J., Finney Hayward T.K., and Nicholson A.G. Different mitogen-activated protein kinase-dependent cytokine responses in cells of the monocyte lineage. J. Pharmacol. Exp. Ther. 324 (2008) 306-312
17. Yang Z., Kondo T., and Voorhorst C.S. Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutants. Mol. Cell. Biol. 29 (2009) 4376-4393
18. Wang J.H., Yu B., and Niu H.Y. C-jun N-terminal kinase-mediated signaling is essential for Staphylococcus aureus-induced U937 apoptosis. Chin. Med. Sci. J. 24 (2009) 26-29
19. Utsugi M., Dobashi K., and Ishizuka T. c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production. J. Immunol. 171 (2003) 628-635
20. Schaffner A., Rhyn P., Schoedon G., and Schaer D.J. Regulated expression of platelet factor 4 in human monocytes-role of PARs as a quantitatively important monocyte activation pathway. J. Leukoc. Biol. 78 (2005) 202-209